4//SEC Filing
Powell Fred M 4
Accession 0001209191-21-040337
CIK 0001016169other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:24 PM ET
Size
11.4 KB
Accession
0001209191-21-040337
Insider Transaction Report
Form 4
Powell Fred M
Senior Vice President & CFO
Transactions
- Tax Payment
Common Stock
2021-06-13$4.45/sh−11,880$52,866→ 761,652 total - Award
Stock Option (right to buy)
2021-06-10+163,963→ 163,963 totalExercise: $4.42Exp: 2031-06-10→ Common Stock (163,963 underlying) - Award
Common Stock
2021-06-10$4.42/sh+85,973$380,001→ 790,859 total - Tax Payment
Common Stock
2021-06-13$4.45/sh−17,327$77,105→ 773,532 total
Footnotes (4)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
- [F3]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F4]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001331339
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:24 PM ET
- Size
- 11.4 KB